Mirum Pharmaceuticals, Inc.

Associate Director, Publications

Mirum Pharmaceuticals, Inc.  •  $195k - $215k/yr  •  Foster City, CA (Hybrid)  •  7 days ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

MISSION

Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.

The Associate Director of Publications manages external publication vendors as well as edits medically relevant scientific presentations (i.e., clinical, scientific, and health economics, abstracts, posters, and oral presentations) to fulfill scientific and medical objectives, in accordance with authors’ direction and in adherence to Publication Policy Procedures and ICMJE and GPP3 guidelines. Assists with the creation of other scientific documents (e.g., medical science liaison [MSL] training slide decks, training tools, and FAQs). Communicates effectively with external authors and internal stakeholders and presents project updates to Sr. Director VLX GMAT Team, Executive Director, Publications, Executive Director, Medical Affairs, Senior Vice President of Medical Affairs, and Mirum Senior Leadership.

JOB FUNCTIONS/RESPONSIBILITIES

Key Responsibilities:

  • Understand scientific and medical content in given areas of the company.
  • Review and edit scientific content for oral and poster presentations at congresses.
  • Manage publications vendor and work closely with key internal and external stakeholders.
  • Implement the publication management system (Datavision).
  • Development of scientific training tactics (eg, internal training MSL decks, tools, FAQs).
  • Engage internal and external subject matter experts, when appropriate, for participation in scientific communication tactics and content development.
  • Manage and contribute to global publication and scientific communications plans for the company needs.

Other Responsibilities:

  • Work effectively with our Medical Communications Agency on publication strategies and deliverables.
  • Learn and apply knowledge of therapeutic area data to scientific publishing projects focused on congress presentations.
  • Operationally execute all activities to agreed timelines related to the preparation of scientific medical publications (i.e., medical, scientific, and health economics abstracts, posters, and oral presentations).
  • Assist with Medical Legal and Regulatory (MLR) Committee review and approvals.
  • Interface with external experts (e.g., physicians, other health care professionals) and effectively collaborate with Clinical Research and Development colleagues, along with other Mirum stakeholders including, but not limited to, Compliance, Safety, Biostatistics, Clinical Operations, and the Commercial group to ensure accurate and timely completion/delivery of information, including addressing conflicting demands, and review of scientific presentations and training programs.

QUALIFICATIONS

Education /Experience:

  • Advanced degree with 5-7+ yrs. experience in scientific communication, training, and/or publications planning and development in an agency or pharmaceutical environment or applicable experience working in pharmaceutical environment with transferable skill set.
  • Demonstrated strong project management skills and leadership poise a must to negotiate and facilitate alignment amongst internal and external stakeholders (KOLs, authors, cross functional teams).
  • Experience working with cross-functional stakeholders and/or agencies to develop abstracts, posters, and oral presentations.
  • Excellent and effective interpersonal and communication skills.
  • Must be well organized and able to multi-task in a fast-paced deadline driven environment
  • Demonstrated experience managing vendors and budgets.

Knowledge, Skills and Abilities:

  • Advanced computer and Internet skills, including knowledge of MS applications such as Word, PowerPoint, Excel, Veeva RIM, electronic publication management tools (e.g., PubStrat and Datavision), references databases (e.g., EndNote), PubMed, etc.
  • Ability to travel (US and International) approximately 30% of time.

The salary range for this position is $195,000 to $215,000 USD. Compensation will be determined based on several factors including, but not limited to; skill set, years of experience, and the employee’s geographic location. Please note that the required compensation details listed in US role postings reflect the base salary only, and do not include bonus, equity, or benefits unless otherwise provided.

#LI-HYBRID

Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.

Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.

Mirum Pharmaceuticals, Inc.

About Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three approved medications: LIVMARLI® (maralixibat), CHOLBAM® (cholic acid) capsules, and CTEXLI™ (chenodiol) tablets.

LIVMARLI, an IBAT inhibitor, is approved for the treatment of two rare liver diseases affecting children and adults. It is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the U.S. (three months and older), in Europe (two months and older), and in other regions globally. It is also approved in the U.S. in cholestatic pruritus in PFIC patients 12 months of age and older; in Europe, it is approved for patients with PFIC three months of age and older. Mirum is also initiating the Phase 3 EXPAND study, a label expansion opportunity for LIVMARLI in additional settings of cholestatic pruritus. CHOLBAM is FDA-approved for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders in patients who show signs or symptoms of liver disease. CTEXLI is FDA-approved for the treatment of cerebrotendinous xanthomatosis (CTX) in adults.

Mirum's late-stage pipeline includes two investigational treatments for several rare diseases. Volixibat, an IBAT inhibitor, is being evaluated in two potentially registrational studies including the Phase 2 VISTAS study for primary sclerosing cholangitis (PSC) and Phase 2b VANTAGE study for primary biliary cholangitis (PBC). Volixibat has been granted Breakthrough Therapy Designation for the treatment of cholestatic pruritus in patients with PBC. Mirum is also planning for a Phase 2 study evaluating MRM-3379, a PDE4D inhibitor for the treatment of Fragile X syndrome, a rare genetic neurocognitive disorder.

Industry
Chemicals & Materials
Company Size
201-500 employees
Headquarters
Foster City, CA
Year Founded
2018
Social Media